Trial Profile
Peripheral neuropathy induced by Bortezomib in patients with multiple myeloma.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 May 2016
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions
- 17 May 2016 New trial record